Related Experiment Videos
Passage of Amipaque (metrizamide) through the arachnoid granulations
Abstract:
125I labelled Amipaque (metrizamide) was introduced by cisternal puncture into six rabbits and perfused at various pressures. The torcular was exposed, frozen rapidly, and excised intact. Sections of arachnoid proliferations were made from the frozen specimen and either freeze dried or sandwiched directly for autoradiography. Some specimens were freeze dried en bloc prior to sectioning and sandwiching. All sections were exposed for 2-3 weeks at -80 degrees C prior to development of the autoradiographs. On microscopic examinations of the autoradiographs most of the activity was in the tubules or between cells suggesting intercellular passage. Some label was also present within the brain. The significance of this is discussed.
Insights
Radioactive Amipaque (metrizamide) injected into rabbits showed it primarily passed between cells in the arachnoid, with some entering brain tissue. This suggests an intercellular pathway for contrast agent distribution.
Area of Science:
- Radiology
- Neuroscience
- Pharmacology
Background:
- Amipaque (metrizamide) is a radiocontrast agent used in neuroradiology.
- Understanding the distribution and passage of contrast agents within the central nervous system is crucial for interpreting imaging studies and assessing potential toxicity.
Purpose of the Study:
- To investigate the distribution and passage of 125I labelled Amipaque (metrizamide) within the arachnoid space and brain tissue of rabbits.
- To elucidate the mechanism of contrast agent passage, specifically focusing on intercellular versus intracellular routes.
Main Methods:
- 125I labelled Amipaque (metrizamide) was administered via cisternal puncture in six rabbits.
- The torcular was rapidly frozen and excised for specimen preparation.
- Autoradiography was performed on freeze-dried or directly sandwiched sections of arachnoid proliferations.
- Sections were exposed at -80°C for 2-3 weeks before autoradiograph development.
Main Results:
- Autoradiographic examination revealed that most of the radioactive label was localized within tubules or intercellular spaces.
- Evidence suggested intercellular passage of Amipaque (metrizamide).
- Some radioactive label was also detected within the brain parenchyma.
Conclusions:
- The study suggests that Amipaque (metrizamide) primarily distributes via intercellular pathways within the arachnoid space.
- The presence of label within the brain indicates potential passage across the blood-brain barrier or other routes.
- Further investigation is warranted to fully understand the implications of these findings for contrast agent safety and efficacy.